Opportunities Beyond Pharma in the COVID-19 Vaccine Race
COVID-19, Feature, FinanceSayeed Yousuf Ahmedmcgill business review, mcgill, desautels, desautels faculty of management, MUS, tech & innovation, finance & markets, global news & politics, pharma, big pharma, vaccinology, vaccine, COVID-19, Coronavirus, sayeed yousuf ahmed, Pfizer, Moderna, AstraZeneca, FDA approval, pandemic, World Health Organization, Oxford, biotech, R&D, stock market
Sprint to the Finish: The Race for a COVID-19 Vaccine
COVID-19, Feature, TechClara MacMahon and Omar Katkhudamcgill business review, mcgill, desautels, desautels faculty of management, MUS, tech & innovation, finance & markets, global news & politics, COVID-19, Coronavirus, biotech, vaccine, vaccinology, World Health Organization, Moderna, United States of America, China, Clara MacMahon, Omar Katkhuda, CanSino, AstraZeneca, Oxford, Pfizer, pandemic, FDA approval, R&D, Science and Sustainability
